Ultrasound guided biopsy revealed a grade III, lymph-node positive invasive ductal carcinoma, 10 cm, noted to be estrogen receptor/progesterone receptor (ER/PR) negative and human epidermal growth factor receptor 2 (HER2) positive (Figure 1). The gene discussed is ESR1; the disease is invasive ductal breast carcinoma.